I will be giving a talk on Educating the Next Generation of Biotechnology Founders and Managers at Pittcon in Orlando on March 1st. The talk will be based on my observations in writing Building Biotechnology and editing Best Practices in Biotechnology Education, in addition to the teaching I’ve done on the topic. I’ll be posting […]
Drug Patent Expirations in February 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ZAGAM Mylan sparfloxacin 4,795,751 Feb 4, 2010 TEVETEN Abbott eprosartan mesylate 5,185,351 Feb 9, 2010 MYOVIEW Ge Healthcare technetium tc-99m tetrofosmin kit 5,045,302 Feb 9, 2010 TEVETEN HCT Abbott eprosartan mesylate; hydrochlorothiazide 5,185,351 Feb […]
I’m giving a talk at Pittcon on biotechnology training this spring. As many readers know, I have been very active in biotechnology education through my books and the classes I teach. So, I’ve got a strong sense of the supply-side of biotechnology education and training, and the academic side of biotechnology education, but would like […]
Moira Gunn’s Tech Nation interview of Jeremy Abbate and I on the Scientific American worldView project is now available at IT Conversations. For more details, you can also see our video interview and the worldView website.
I’m honored to have been selected as one of the judges of the 2010 Biotech Humanitarian award. More details are available in a press release and blog post about the award. The Biotechnology Industry Association created the Award to recognize an everyday hero who has helped to heal, fuel and feed the planet through their work […]
The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 16, Issue 1 Editorial Time for a new business model? PDF Yali Friedman Commentary Why data exclusivity is the new patent protection PDF Peter J Pitts Follow-on biologic drug […]
Drug Patent Expirations in January 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration XOPENEX Sepracor levalbuterol hydrochloride 6,083,993 Jan 5, 2010 XOPENEX HFA Sepracor levalbuterol tartrate 5,844,002 Jan 5, 2010 XOPENEX Sepracor levalbuterol hydrochloride 5,844,002 Jan 5, 2010 XOPENEX HFA Sepracor levalbuterol tartrate 5,760,090 Jan 5, 2010 […]